WM-662 - Moligand™, 10 mM in DMSO , CAS No.1308257-47-7

CAS: 1308257-47-7 Cat. No.: W1498042 Formule: C19H18ClN5O4 Poids moléculaire: 415.83
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10 mM in DMSO
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Taille
Allemagne (EU)
USA*
Prix
Qté
1ml
W1498042-1ml
Sur commande · 8–12 semaines
522,29€
Enter a quantity for the sizes you want to add.

Vue d’ensemble

WM-662 is a WDR5-MYC interaction inhibitor, with an IC 50 of 18 μM. WM-662 has potential for the research of cancer , aging, and neurodegenerative disorders.

Spécifications

Spécifications et pureté
Moligand™, 10 mM in DMSO
Conditions de stockage de stockage
Store at -80°C
Expédié en
Dry ice packs + Cold packs
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Grade
Moligand™
Noms et identifiants
Poids moléculaire
415.83

Données avancées

Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Avis

Avis des clients

Application Protocols

Item-specific facts (from Product Data)

  • No tested applications are specified for WM-662.

General example protocols (for small-molecule screening compounds)

  • DMSO stock preparation
    • Equilibrate vial to room temperature in a desiccator.
    • Add anhydrous DMSO to achieve 10–50 mM; vortex until fully dissolved.
    • Optional: Clarify by brief sonication. Verify by LC–MS/HPLC.
    • Aliquot into low-bind tubes to minimize freeze–thaw.
  • Biochemical assay dosing
    • Prepare serial dilutions in DMSO (e.g., 3-fold or 10-fold).
    • Spike into assay buffer to achieve target concentrations with constant final DMSO (≤0.1–1.0% v/v).
    • Include vehicle and positive control wells; incubate per assay SOP.
  • Cell-based assay dosing
    • Prepare intermediate dilutions in media-compatible solvent (≤0.1% DMSO final where possible).
    • Add to cells gently to avoid precipitation; mix by plate shaking.
    • Monitor for solvent toxicity via vehicle controls.
  • Analytical confirmation
    • After assays, confirm compound integrity by re-injecting residual solution on LC–MS/HPLC to rule out decomposition or adsorption losses.
Biological Roles

Item-specific facts (from Product Data)

  • No target, pathway, or biological role is specified for WM-662. Research use only.

General guidance

  • Nature of material: WM-662 is supplied as a Moligand™ small-molecule compound intended for discovery research, not as an endogenous metabolite or biologic. Any biological activity should be established empirically in your system of interest.
  • Use as a probe candidate: If WM-662 demonstrates selective, potent modulation in your assays with acceptable off-target and physicochemical profiles, it may serve as a chemical probe candidate. Formal probe qualification typically requires orthogonal validation, inactive control analogs, evidence of on-target engagement (e.g., CETSA, DARTS, pull-down), and cellular phenocopy.
  • ADME/tox considerations: Before in vivo exploration (if permitted by institutional policies), establish solubility, permeability, metabolic stability, and basic safety flags in vitro. No claims are made here regarding suitability for in vivo use.
  • Data integrity: Track lot numbers, storage history, and number of freeze–thaw cycles to ensure biological results can be reproduced and attributed correctly.
  • Documentation: If a putative target emerges, annotate assays with target class, species, binding mode (if known), and observed potency metrics (IC50, EC50, KD), all generated in your lab or provided under NDA. No such data are provided in this listing.
Buffer Applications

Applicability

  • WM-662 is a small-molecule research compound and not a buffering reagent. It does not define a pH range or buffering capacity.

Practical notes for assay buffers (general)

  • Vehicle control: Prepare matched vehicle controls containing the same final DMSO (or other solvent) concentration as used for WM-662.
  • Precipitation avoidance: Add compound stocks last, with vigorous mixing, into pre-equilibrated buffers. Include non-ionic detergent (e.g., 0.01–0.05% Tween-20) if compatible to mitigate aggregation.
  • Common buffer systems: Use assay-appropriate buffers (e.g., HEPES pH 7.2–7.5 for enzymes, PBS for cellular assays, Tris for biochemical work). Validate compound stability at the chosen pH and ionic strength.
  • Adsorption control: For hydrophobic compounds, include carrier proteins (0.1–0.5% BSA) where assay design allows to reduce nonspecific binding to plastics.
  • Filtration: If particulate forms after dilution, low-protein-binding filters (0.22 µm) may help, provided no significant compound loss occurs (test recovery).
Green Alternatives

Context

  • With structure and specific solvents not provided, solvent strategy is the main lever for greener practice when working with WM-662.

Greener handling suggestions (general)

  • Stock solutions: Maintain concentrated stocks in DMSO to minimize total solvent volumes; DMSO is of moderate environmental impact compared with chlorinated solvents.
  • Assay dilutions: Favor aqueous buffers with minimal organic co-solvent (≤0.1–0.5% v/v) where assay tolerates it.
  • Avoidance: Reduce or eliminate chlorinated solvents (DCM, chloroform) in analytical workups and switching; prefer ethyl acetate or MeTHF where feasible.
  • Cleaning: Use water/ethanol or isopropanol for glassware rinse-down instead of acetone/DCM when compatible.

Illustrative comparison (general; choose as appropriate to your lab)

  • DCM vs Ethyl acetate: EtOAc is less hazardous and has lower environmental persistence; use EtOAc/heptane for normal-phase methods rather than DCM.
  • DMF vs 2-MeTHF/EtOH for sample prep: When dissolving for non-biological analytics, 2-MeTHF or ethanol may substitute DMF in some cases; for biological assays, DMSO remains standard due to compatibility.

Notes

  • Selection must respect assay requirements and compound compatibility. Confirm solubility and chemical stability in any alternative solvent prior to adoption.
Pharmaceutical Uses

Applicability

  • No pharmaceutical excipient role, compendial status, or formulation specifications are provided or implied for WM-662. It is supplied strictly for research use only.

General context for discovery settings

  • Preformulation screens (research): If WM-662 progresses in discovery workflows, exploratory solubility and stability studies may be conducted in common preclinical vehicles (e.g., 10–20% PEG400, 10% Solutol HS15, 10% ethanol in saline). Such activities are research-stage only and must follow institutional policies.
  • No medical/clinical claims: WM-662 is not approved for human or veterinary use. Do not use in diagnostic procedures or as a drug substance/excipient.
  • Documentation: For any future development, compendial monographs, residual solvent limits, elemental impurities, and stability protocols would need to be established de novo; none are provided for this item.
Physical Properties

Item-specific facts (from Product Data)

  • Physical state/appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Other specifications (bp, mp, density, refractive index, water content, residual solvents): Not specified for this item; refer to CoA/Spec Sheet.

General/literature guidance for small-molecule screening compounds

  • Solubility: In the absence of structure-dependent data, prepare a primary stock in anhydrous DMSO (commonly 10–50 mM) and confirm clarity by visual inspection and LC/UV. If precipitation occurs upon aqueous dilution, titrate co-solvent (DMSO 0.1–1% v/v in assay) or use cosolvents such as ethanol or minimal DMF, consistent with assay tolerance.
  • Polymorphism/hygroscopicity: Unknown; handle in a low-humidity environment until verified. Record any mass gain on exposure to air.
  • Stability: Without structural info, assume light and moisture sensitivity is possible; protect from light, store at –80°C per product data, and minimize freeze–thaw.
  • pKa/logP: Not specified for this item. If required, determine experimentally (potentiometric, UV-metric) or estimate computationally only after structure disclosure.
  • Chromatographic behavior: If running purity checks, start with reverse-phase C18 gradients (e.g., 5–95% acetonitrile/water with 0.1% formic acid) and adjust based on retention; confirm mass by LC–MS.
Quality and Grades

Item-specific facts (from Product Data)

  • Grade: Moligand™
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.

Interpretation and guidance

  • Moligand™ context: This designation indicates a research-only small-molecule ligand/tool compound suitable for screening, mechanistic studies, or probe development. Such materials are typically provided with purity control by chromatographic and/or spectrometric methods; however, exact acceptance criteria (e.g., HPLC area %, NMR identity, residual solvent limits) are not specified here and should be confirmed on the CoA.
  • Documentation: For regulated workflows, request a full analytical package (HPLC/UPLC trace, LC–MS, 1H/13C NMR if available, water content, residual solvents). If the structure is confidential, identity may be supported by an internal reference spectrum rather than a public structure.
  • Stabilizers/inhibitors: None are listed for this item. If stabilizers are present, they will be indicated on the CoA. Do not assume the presence or absence of antioxidants or acid scavengers.
  • Batch-to-batch considerations: For screening campaigns, lock a single lot if possible. If switching lots, re-qualify concentration by quantitative NMR or UV assay (if chromophore known) and confirm biological baseline in control assays.
  • Suitability: Moligand™ grade is intended for discovery research and not for GMP manufacturing, clinical use, or diagnostic procedures.
Reaction and Applications

Item-specific facts (from Product Data)

  • Application scope from catalog: Not specified beyond inclusion in a small-molecule/compound library (Moligand™). Research use only.

Practical research applications (general)

  • Tool compound candidate: WM-662 can be evaluated in biochemical or cell-based assays as a putative ligand or modulator once its structure and putative target class are known within your project. Use as a blinded or partially disclosed screening entity in hit validation cascades.
  • Assay deployment: Typical workflows include primary screening (biochemical or phenotypic), orthogonal confirmation (alternate readout), selectivity panels, and basic ADME profiling (solubility, stability in microsomes, permeability) once sufficient material is available.
  • Analytical qualification: Verify identity/purity by LC–MS and HPLC before biological testing. Quantify DMSO stock concentration by qNMR against an internal standard when extinction coefficient is unknown.
  • Controls and artifacts: Include counterscreens for aggregation (detergent challenge, dynamic light scattering), redox cycling, fluorescence interference, and metal chelation, especially when structural alerts are not known.
  • Mechanistic follow-up: If activity is observed, determine modality (competitive/noncompetitive, covalent/reversible) via kinetics and MS adduct checks. Map SAR with related analogs if accessible through the same library provider.
Reaction Conditions

Applicability

  • WM-662 is not described as a reagent for chemical synthesis; therefore, standard reaction conditions are not applicable.

General handling/usage conditions for testing

  • Stock preparation: Dissolve in anhydrous DMSO to 10–50 mM, vortex, and sonicate briefly if needed. Filter through 0.22 µm PTFE only after confirming negligible adsorption.
  • Assay conditions: Typical biochemical assays are run at ambient temperature or 30–37°C depending on enzyme/cell system, with final organic co-solvent kept consistent across test and control wells (commonly ≤0.1–1.0% v/v DMSO). Incubation times depend on assay kinetics (minutes to hours). These are general guidelines; optimize per your protocol.
  • Stability checks: Evaluate time-dependent potency shifts by pre-incubation studies and by repeating LC–MS after assay exposure to confirm chemical integrity.
  • Light sensitivity: In the absence of data, protect from light during preparation and testing to avoid photodegradation artifacts.
Safety and Handling

Item-specific facts (from Product Data)

  • GHS classification, signal word, pictograms, H-statements: Not specified for this item; refer to the SDS.
  • Storage: Store at –80°C.
  • Shipping: Shipped on dry ice packs + cold packs.

General safety guidance (not a substitute for SDS)

  • Unknown hazard profile: In the absence of a disclosed structure or hazard classification, treat WM-662 as a potentially harmful organic compound. Work in a chemical fume hood. Avoid inhalation, ingestion, and skin/eye contact.
  • PPE: Lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). For weighing powders or handling concentrated solutions, consider double-gloving and using a dust mask/respirator as required by institutional policy.
  • Handling: Open vials only after equilibrating to room temperature in a desiccator to prevent condensation. For solids, minimize dust formation. For solutions, avoid aerosolization.
  • Incompatibilities: Without structure data, avoid strong oxidizers/reducers, strong acids/bases, and reactive metals until compatibility is known. Keep away from ignition sources.
  • First aid (overview): Skin/eye contact—rinse with water for at least 15 minutes; remove contaminated clothing. Inhalation—move to fresh air. Ingestion—rinse mouth; do not induce vomiting; seek medical attention. Always defer to the SDS and institutional EHS guidance.
  • Waste: Collect in halogenated or non-halogenated organic waste as appropriate once solvent system is known; label as “research chemical—hazards unknown.”
Solvent Selection

Item-specific facts (from Product Data)

  • No solubility or polarity data are provided for WM-662; consult the CoA/Spec Sheet.

General guidance for small-molecule tool compounds

  • Primary stock solvent: DMSO is the standard vehicle for discovery compounds due to broad solubilizing power and assay compatibility at ≤0.1–1.0% v/v. Start with 10–50 mM stocks.
  • Aqueous dilution: Dilute DMSO stocks into assay buffers slowly with vortexing to minimize precipitation. Maintain consistent final DMSO across controls and test wells.
  • Alternative vehicles: If DMSO is restricted, consider ethanol or PEG400/water mixtures. Limited amounts of DMF or acetonitrile can be used in method development but may be less biocompatible.
  • Solubility screening workflow:
    • Prepare serial stocks (e.g., 5, 10, 25, 50 mM in DMSO).
    • Dilute to target assay concentrations while keeping solvent constant.
    • Inspect visually and by light scattering; confirm by LC–UV or nephelometry.
  • pH effects: If ionizable, solubility may improve at extreme pH, but biological assays typically require near-neutral pH; use minimal pH adjustment to avoid assay artifacts.
  • Comparators: When method development requires matched polarity, choose reference compounds with known solubility/behavior in your assay and bracket WM-662 alongside them.
Storage and Reconstitution

Item-specific facts (from Product Data)

  • Storage conditions: Store at –80°C.
  • Shipped in: Dry ice packs + cold packs.
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.

General handling and reconstitution guidance

  • Upon receipt: Verify package integrity and temperature. Transfer immediately to –80°C storage. If long-term storage at –80°C is not feasible, consult Aladdin Scientific for guidance; do not substitute higher temperatures without stability data.
  • Moisture/light protection: Store in original, tightly sealed container under inert gas if available. Protect from light. Include desiccant in secondary containment.
  • Reconstitution: For most small molecules, dissolve in anhydrous DMSO to make a concentrated stock (e.g., 10–50 mM). Mix thoroughly until clear. If solubility is uncertain, start at lower concentration and titrate upward.
  • Aliquoting: Dispense single-use aliquots in low-bind cryovials to minimize freeze–thaw cycles. Record aliquot map and lot/aliquot IDs in your ELN.
  • Freeze–thaw management: Avoid repeated thawing; thaw on ice or at room temperature briefly, use immediately, and refreeze remaining aliquots promptly. Discard aliquots showing precipitation or discoloration unless purity is reconfirmed by LC–MS.
  • Stability: No specific shelf-life is provided for WM-662. For ongoing studies, periodically reassess purity (HPLC/LC–MS) and concentration (qNMR/UV if applicable). Refer to the CoA for any item-specific stability statements.
Structure and Identity

Item-specific facts (from Product Data)

  • Product name: WM-662 (SKU: W1498042)
  • CAS: 1308257-47-7
  • Grade/Purity: Moligand™
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

General notes

  • Structural features: The specific structure of WM-662 is not provided in the current product data. Without a SMILES/InChIKey, ring systems, functional groups, and stereochemistry cannot be detailed. Please consult the Certificate of Analysis (CoA) or request structural disclosure, if available, for cheminformatics use (SAR, docking, vendor filtering).
  • Category: Listed under small molecules and compound library (screening/ligand discovery context). Moligand™ items are typically intended as research ligands, tool candidates, or screening hits/leads; they are not validated drugs and are supplied for laboratory research only.
  • Registry utility: The CAS number enables unambiguous cross-referencing across databases and ELNs. If you maintain internal compound IDs, map SKU W1498042 and CAS 1308257-47-7 to your registry to avoid duplication.
  • Informatics placeholders: If structure is confidential or pending, you may track physicochemical descriptors (cLogP, TPSA, HBD/HBA) once the structure is known; until then, treat WM-662 as “structure not disclosed” and avoid QSAR or structural alerts workflows that require explicit connectivity.
Synthetic Utility

Applicability

  • WM-662 is offered as a finished small-molecule research compound (Moligand™) and is not positioned as a reagent, catalyst, or building block. Without structural information, synthetic transformations, reactivity, or functional group interconversions cannot be meaningfully described.

General notes

  • If your program intends to derivatize WM-662 or design analogs, please request structural disclosure or a suitable intermediate/building block from the supplier. Absent that, de novo route design and library expansion cannot be planned.
  • For analytical method development or stability-indicating assays, focus on profiling in multiple stress conditions (acid/base/oxidative/thermal) to infer potential liability motifs, but do not perform synthetic modifications unless structure is known and IACUC/IRB/EHS approvals allow such work.
Target Specificity

Item-specific facts (from Product Data)

  • No target, mechanism, or specificity information is provided for WM-662.

General guidance

  • If WM-662 is employed as a candidate probe, determine specificity through a panel of related targets, counterscreens, and orthogonal assay formats. Techniques such as CETSA or SPR can complement enzymatic IC50/EC50 data to infer direct binding.
  • Report species selectivity and off-target profiles when available. None are provided here.

Foire aux questions

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?80 °C. Ultra-low temperature storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1308257-47-7, the molecular formula is C19H18ClN5O4, and the molecular weight is 415.83 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Besoin d'aide pour choisir la qualité ?

Notre guide de sélection des qualités couvre la pureté, le statut du stabilisant et l'adéquation à l'application pour toutes les variantes de notre catalogue.

Voir le guide des qualités Moligand™ →

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.